Evonik, a CMO provider for API and advanced intermediates, has completed a €36 million expansion of its contract manufacturing capabilities in the U.S. and Europe. Evonik has introduced a series of advanced technologies, including high-potency API (HPAPI), fermentation, mPEGs and continuous processing, at multiple production sites over the last year.  “Our mission is to help our customers bring to market innovative molecules with complex manufacturing processes, and in this context, global sc...